HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 16.30
+1.81 (12.49%)
Aug 20, 2026, 4:09 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 14.14 billion as of August 20, 2026. Its market cap has increased by 45.78% in one year.
Market Cap
14.14B
Enterprise Value
11.64B
Revenue
1.23B
Ranking
n/a
PE Ratio
19.04
Stock Price
16.30
ChartMarket Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 14.14B, an increase of 67.12%. That is a compound annual growth rate of 9.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 14.14B | 39.11% |
| Dec 31, 2025 | 10.17B | 646.15% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 16.42B |
| Nanjing Leads Biolabs | 14.01B |
| Metis TechBio | 13.86B |
| Ascentage Pharma Group International | 12.79B |
| GenFleet Therapeutics (Shanghai) | 11.04B |
| Ascletis Pharma | 10.38B |
| Shaanxi Micot Pharmaceutical Technology | 10.15B |
| TenNor Therapeutics (Suzhou) | 9.31B |